✦ LIBER ✦

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

✍ Scribed by Curry, Michael P.; Forns, Xavier; Chung, Raymond T.; Terrault, Norah A.; Brown, Robert; Fenkel, Jonathan M.; Gordon, Fredric; O’Leary, Jacqueline; Kuo, Alexander; Schiano, Thomas; Everson, Gregory; Schiff, Eugene; Befeler, Alex; Gane, Edward; Saab, Sammy; McHutchison, John G.; Subramanian, G. Mani; Symonds, William T.; Denning, Jill; McNair, Lindsay; Arterburn, Sarah; Svarovskaia, Evguenia; Moonka, Dilip; Afdhal, Nezam

Book ID: 127385556
Publisher: Elsevier Science
Year: 2015
Tongue: English
Weight: 595 KB
Volume: 148
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2014.09.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential net health benefit of pre-tran

Potential net health benefit of pre-transplant Sofosbuvir to prevent recurrence of HCV infection after liver transplantation: A multicenter, cohort model study

✍ Vitale, A.; Spolverato, G.; Burra, P.; De Feo, T.M.; Belli, L.; Donato, F.; Sveg 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 66 KB

P1232 SOFOSBUVIR AND RIBAVIRIN FOR THE T

P1232 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C INFECTION AFTER LIVER TRANSPLANTATION: RESULTS OF A PROSPECTIVE, MULTICENTER STUDY

✍ Samuel, D.; Charlton, M.; Gane, E.; Brown, R.; Curry, M.; Kwo, P.; Fontana, R.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Combination therapy with peginterferon a

Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study

✍ S Beckebaum; V.R Cicinnati; X Zhang; M Malago; O Dirsch; Y Erim; A Frilling; C.E 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Treatment of the “Uncommon” HCV Genotype

Treatment of the “Uncommon” HCV Genotype 4 Infection Recurrence After Liver Transplantation. An “Aisf Recolt-C” Study

✍ Ponziani, Francesca R. ;Milani, Alessandro ;Gasbarrini, Antonio ;Viganò, Raffael 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P.1.54: TREATMENT OF THE “UNCOMMON” HCV

P.1.54: TREATMENT OF THE “UNCOMMON” HCV GENOTYPE 4 INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION. AN “AISF RECOLT-C” STUDY

✍ F.R. Ponziani; A. Milani; A. Gasbarrini; R. Viganò; M. Marino; M.F. Donato; M. R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Impact of pegylated interferon α-2B and

Impact of pegylated interferon α-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series

✍ Sandeep Mukherjee; Elizabeth Lyden 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB